Olympus Corporation

Veterinary Electrosurgery Market worth $120 million | MarketsandMarkets

Retrieved on: 
Tuesday, October 10, 2023
Control, Integra, Partnership, Acquisition, DACH, Bleeding, Risk, Animal, DRE, Coagulation, Olympus Corporation, Integra LifeSciences, Blood, Trauma, Anesthesia, Scar, Infection, Antibody-drug conjugate, Veterinarian, Tissue, Electrosurgery, Veterinary medicine, Symmetry, Medical device, Birth control, Dentistry, Medtronic

In April 2021, DRE Veterinary (US) partnered with Avante Health Solutions (US).

Key Points: 
  • In April 2021, DRE Veterinary (US) partnered with Avante Health Solutions (US).
  • Minimally Invasive: Electrosurgery is often minimally invasive, resulting in smaller incisions, less pain, and reduced scarring for animals post-surgery.
  • Versatility: Electrosurgical instruments can be adapted for various veterinary procedures, including soft tissue surgeries, dermatological treatments, and ophthalmic surgeries, making them versatile tools in veterinary medicine.
  • Enhanced Patient Outcomes: Overall, the advantages of electrosurgery contribute to improved patient outcomes, making it a valuable tool for modern veterinary practices and promoting the well-being of animals.

Novel iTind Procedure Now Included in Treatment Guideline for Lower Urinary Tract Symptoms Caused by Enlarged Prostate

Retrieved on: 
Thursday, September 28, 2023
Urine, BPH, AUA, LUTS, Urination, Quality of life, Urinary tract infection, American Urological Association, Olympus Corporation, Research, Prostate, National Prostate Health Month, Patient, Physician, Blood, Ageing, Medical imaging

CENTER VALLEY, Pa., Sept. 28, 2023 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer, and more fulfilling, announced today that its iTind™ procedure is now included in the American Urological Association (AUA) clinical practice guideline for management of lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH), also known as enlarged prostate. The iTind procedure is reflected in the new procedure category, Temporary Implanted Prostatic Devices (TIPD).i The addition of the TIPD category is based on expert opinion reflecting peer-reviewed treatment recommendations and research updates.

Key Points: 
  • The iTind procedure is reflected in the new procedure category, Temporary Implanted Prostatic Devices (TIPD).i The addition of the TIPD category is based on expert opinion reflecting peer-reviewed treatment recommendations and research updates.
  • The minimally invasive iTind procedure involves the placement of a temporarily implanted nitinol device that reshapes the prostatic urethra without burning or cutting out the prostate.
  • "This guidance reflects compelling clinical evidence and positive clinical experience with the iTind procedure."
  • In rare cases, the iTind device may cause urinary tract infection or a sudden difficulty to urinate.

Single-use Rhinolaryngoscope Now Distributed Exclusively by Olympus

Retrieved on: 
Monday, September 18, 2023
Contraindication, Injection, ENT, American Academy of Otolaryngology–Head and Neck Surgery, Society, Bleeding, Use, AAO, Senior, ARS, Workflow, Olympus, American Academy, Perforation, Olympus Corporation, Endoscopy, Sale, Congress, Patient, Physician, Nursing, Annual general meeting, Diagnosis, SOHN, Pharmaceutical industry, Medical imaging

WESTBOROUGH, Mass., Sept. 18, 2023 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today the launch of the Vathin E-SteriScope™ single-use flexible video rhinolaryngoscope for use in diagnostic and therapeutic otorhinolaryngological procedures. The E-SteriScope single-use flexible video rhinolaryngoscope is manufactured by Hunan Vathin Medical Instrument Co., Ltd., and distributed exclusively by Olympus. It is now available for sale in the U.S., with availability in Europe, Middle East and Africa anticipated later this year.

Key Points: 
  • The E-SteriScope single-use flexible video rhinolaryngoscope is manufactured by Hunan Vathin Medical Instrument Co., Ltd., and distributed exclusively by Olympus.
  • As a leader in endoscopy, Olympus is committed to offering a comprehensive endoscopy portfolio that includes a full range of access, visualization, and therapeutic ENT endoscopy solutions.
  • "We are very excited to launch this single-use rhinolaryngoscope as a complement to the full Olympus ENT portfolio," said Gabriel McHugh, Senior Vice President for Therapeutic Solutions at Olympus Corporation.
  • For more information about the E-SteriScope single-use flexible video rhinolaryngoscope, visit the Olympus America website: medical.olympusamerica.com/products/e-steriscope

Olympus Adopts AcuityMD Across the Enterprise to Power an Expanding Omnichannel Engagement Strategy

Retrieved on: 
Tuesday, September 12, 2023
Data Management, Health, Technology, Health Technology, Software, General Health, Biotechnology, Partnership, Surgeon, Olympus Corporation, Patient, Physician, CRM, Urology, Medtech, Pharmaceutical industry, Sales, Cryptocurrency, Gastroenterology, Flywheel

Olympus is leveraging AcuityMD not only to expand business opportunities but also to continue building its omnichannel strategy and improve the customer experience with personalized engagement.

Key Points: 
  • Olympus is leveraging AcuityMD not only to expand business opportunities but also to continue building its omnichannel strategy and improve the customer experience with personalized engagement.
  • Olympus sought an industry-specific commercial solution that combines accurate data, analytics, and customer relationship management functionality in one easy-to-use platform.
  • Olympus is now expanding its use of AcuityMD’s Targeting Module across its Urology, Gastroenterology, and Respiratory business units and is using the platform to further build its omnichannel engagement strategy.
  • “The customer is at the center of everything we do,” said Suzan Morgan, head of omnichannel strategy at Olympus.

Growing Healthcare Expenditure and Prevalence of Chronic Diseases Drive the Global Endoscopy Market - ResearchAndMarkets.com

Retrieved on: 
Monday, August 21, 2023
General Health, Health, Surgery, Medical Devices, Arthroscopy, Prevalence, Boston Scientific, Ageing, Cancer, Ethicon, Laparoscopy, Olympus Corporation, Endoscopy, Research, Fujifilm, Hospital, Medtronic, Investment, Physician, Risk, Conditional sentence, Johnson & Johnson, Abdominal ultrasonography, Pharmaceutical industry

The global endoscopy market is projected to reach a value of US$52.08 billion by 2027, growing at a CAGR of 7.50% during the forecast period 2023-2027.

Key Points: 
  • The global endoscopy market is projected to reach a value of US$52.08 billion by 2027, growing at a CAGR of 7.50% during the forecast period 2023-2027.
  • The market's growth will be driven by factors such as increasing healthcare expenditure, rising prevalence of chronic diseases, a growing obese population, and an aging demographic.
  • The report provides a detailed analysis of the global endoscopy market based on product, application, end-user, and region.
  • The report offers a comprehensive analysis of the global endoscopy market, including market dynamics, growth drivers, trends, and challenges.

Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer

Retrieved on: 
Monday, May 29, 2023
Gender identity, Caregiver, Religion, Marketing, Culture, Parent, Life, Woman, Olympus Corporation, Equity, Interface (computing), Wenley House, DEI, ESG, Region, Environment, Medtech, Cultural diversity, Management, Nursing, Inclusion

TOKYO, May 29, 2023 - (JCN Newswire) - Effective June 1, Wenlei Yang will be named Chief Diversity, Equity and Inclusion Officer for Olympus Corporation (Olympus), a global MedTech company committed to making people's lives healthier, safer and more fulfilling.

Key Points: 
  • TOKYO, May 29, 2023 - (JCN Newswire) - Effective June 1, Wenlei Yang will be named Chief Diversity, Equity and Inclusion Officer for Olympus Corporation (Olympus), a global MedTech company committed to making people's lives healthier, safer and more fulfilling.
  • Effective June 1, Wenlei Yang will be named Chief Diversity, Equity and Inclusion Officer for Olympus Corporation.
  • [Image: Olympus]
    In this newly established role, Wenlei will drive, oversee and implement initiatives related to Olympus' new Diversity, Equity and Inclusion (DEI) directions set as part of the company's global ESG strategy announced on May 12, 2023.
  • Moving forward, Wenlei will continue to represent Japan as the Regional Representative Officer and will also lead initiatives related to Olympus' global DEI strategy.

CellMax Life Appoints Dr. Ross D. "Rusty" Segan to Advisory Board

Retrieved on: 
Wednesday, August 2, 2023
Minimally invasive procedure, University, CRC, Gastroenterology, Cancer, Tripler Army Medical Center, Olympus Corporation, Medicine, Science, Medtronic, University of Maryland Medical Center, United States Department of the Army, Adenoma, Colonoscopy, Johnson & Johnson, Injury, Vaccine, Medical device

SUNNYVALE, Calif., Aug. 2, 2023 /PRNewswire-PRWeb/ -- CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer (CRC) screening blood test, that also detects pre-cancerous polyps, or adenomas, today announced the appointment of Dr. Ross D. Segan as an advisory board member.

Key Points: 
  • CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer (CRC) screening blood test, that also detects pre-cancerous polyps, or adenomas, today announced the appointment of Dr. Ross D. Segan as an advisory board member.
  • SUNNYVALE, Calif., Aug. 2, 2023 /PRNewswire-PRWeb/ -- CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer (CRC) screening blood test, that also detects pre-cancerous polyps, or adenomas, today announced the appointment of Dr. Ross D. Segan as an advisory board member.
  • "Rusty is a visionary in aligning science, medicine and technology, bringing innovations that are clinically relevant into real-life healthcare settings," said Atul Sharan, CEO of CellMax Life.
  • For more information about CellMax Life and its FirstSight test, visit cellmaxlife.com .

Olympus Announces Launch of Newest Systems Integration Solution

Retrieved on: 
Tuesday, July 25, 2023
Software, VNA, Olympus, Olympus Corporation, IP, ES, Acquisition, EHR, Nursing, Windows IoT, Algorithm, Digital, Health, Pharmaceutical industry, Medical device, Video game, Medical imaging

CENTER VALLEY, Pa., July 25, 2023 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today U.S. market availability of EASYSUITE™ ES-IP system, its newest procedure room visualization and integration solution.

Key Points: 
  • CENTER VALLEY, Pa., July 25, 2023 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today U.S. market availability of EASYSUITE™ ES-IP system, its newest procedure room visualization and integration solution.
  • The next generation of EASYSUITE, the ES-IP system is a modular, scalable, workflow-based solution.
  • At its core is the new Olympus digital hub, which offers flexibility to run current software applications and potential future Olympus multi-specialty applications (apps).
  • "The launch of  EASYSUITE™ ES-IP system represents Olympus' commitment to delivering intelligent integrated solutions designed to improve patient care pathways and clinical operations.

Olympus Named to Disability:IN's 2023 Disability Equality Index

Retrieved on: 
Wednesday, July 19, 2023
Bewell's Cross, Human resources, Letter, Partnership, American Association of People with Disabilities, Minister of Employment, Workforce Development and Disability Inclusion, Culture, Workplace, Disability, Olympus, Olympus Corporation, Equity, Human, OCA, Inclusion, DEI, Environment, Health insurance, Nursing, Management

CENTER VALLEY, Pa., July 19, 2023 /PRNewswire/ -- Olympus Corp. of the Americas, a leading medical technology company, announced today that it's been recognized by Disability:IN as one of the 2023 Best Places to Work for People with Disabilities.

Key Points: 
  • Olympus is among the 405 companies that achieved top scorer status on the 2023 DEI and one of only 164 companies that has signed onto Disability:IN's CEO Letter on Disability Inclusion.
  • The Disability Equality Index (DEI) represents a comprehensive tool that helps companies work toward disability inclusion and equality in business.
  • "We're excited to again be included on the Disability Equality Index," said Stacey Morey, Vice President of Human Resources at OCA.
  • "I'm proud to collaborate with those who work to make Olympus inclusive of the people in our respective communities.

Olympus Announces Launch of Next Generation Electrosurgical Generator

Retrieved on: 
Tuesday, June 6, 2023
JML, Urine, BPH, Narrow-band imaging, HF, Urethra, Olympus, American Urological Association, Bladder cancer, Olympus Corporation, Multimedia, Prostate, Needle, LCD, Plasma, Death, Physician, Blood, NBI, Diagnosis, American Cancer Society, System, Ejaculation, Bipolar, Electrosurgery, Injury, Pharmaceutical industry, Medical imaging, Electric battery, Dietary supplement, Online shopping, NMIBC

The ESG-410 Electrosurgical Generator, with its accessories and ancillary equipment, is intended for cutting and coagulation of tissue in open, laparoscopic and endoscopic surgery and should only be used by a qualified physician in an adequate medical environment.

Key Points: 
  • The ESG-410 Electrosurgical Generator, with its accessories and ancillary equipment, is intended for cutting and coagulation of tissue in open, laparoscopic and endoscopic surgery and should only be used by a qualified physician in an adequate medical environment.
  • Improper use or use of incompatible equipment with this electrosurgical generator can lead to excessive or incorrect HF and cause thermal or other injuries for the patient and/or operator.
  • Be aware that if the mains plug is accidentally disconnected during a procedure, the electrosurgical generator immediately turns off and this can result in complications for the patient.
  • At Olympus, we are committed to Our Purpose of making people's lives healthier, safer and more fulfilling.